Using Patient Data to Better Understand Disease Progression
This is a members only resource. If you would like to learn more about PMSA membership, click here.
Description
Diseases like NASH traditionally require an invasive liver biopsy to positively identify patients. When no therapies exist on the market, healthcare providers often hold off on performing a biopsy, resulting in a significant number of undiagnosed patients. By harnessing large clinical encounter data sets, we can begin to understand the patient populations at each stage and severity of disease, leading to better guidance of treatment development and delivery.
Presenters:
- Dr. Aswin Chandrakantan, Chief Medical Officer & SVP Corporate Development, Komodo Health